Zynerba Pharmaceuticals - Delisted Stock
Zynerba Pharmaceuticals is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Zynerba Pharmaceuticals was actively traded.
Valuation
Check how we calculate scores
Zynerba Pharmaceuticals Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Zynerba Pharmaceuticals market risk premium is the additional return an investor will receive from holding Zynerba Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Zynerba Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Zynerba Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Zynerba Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 8.95 | |||
| Semi Deviation | 0.4122 | |||
| Standard Deviation | 36.64 | |||
| Variance | 1342.49 |
View Zynerba Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Zynerba Pharmaceuticals Corporate Directors
Zynerba Pharmaceuticals corporate directors refer to members of a Zynerba Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Zynerba Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Zynerba Pharmaceuticals' board members must vote for the resolution. The Zynerba Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Daniel Kisner | Director Nominee | Profile | |
| William Federici | Director Nominee | Profile | |
| Kenneth Moch | Director Nominee | Profile | |
| Thomas Harrison | Director Nominee | Profile |
Still Interested in Zynerba Pharmaceuticals?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Zynerba Stock
If you are still planning to invest in Zynerba Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zynerba Pharmaceuticals' history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |